Figures and data
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_fig1.tif/full/max/0/default.jpg)
Oxydifficidin isomers inhibit the growth of N. gonorrhoeae.
a. Discovery of a contaminant (Bacillus amyloliquefaciens BK) that inhibited the growth of N. gonorrhoeae. b. Example of known oxydifficidin thermal isomers. c. MIC of oxydifficidin against different bacteria (n = 2). Genome-based phylogenetic tree built using Genome Clustering of MicroScope.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_tbl1.tif/full/max/0/default.jpg)
Susceptibilities of N. gonorrhoeae to antibiotics.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_fig2.tif/full/max/0/default.jpg)
Oxydifficidin-resistant N. gonorrhoeae mutant development and corresponding susceptibilities.
a. Schematic representation of N. gonorrhoeae mutant development that identified dedA. Activity of different antibiotics against WT and dedA gene disrupted N. gonorrhoeae. b. Time-dependent antibiotic killing assay of N. gonorrhoeae strains. Each antibiotic was tested at 8x its MIC for the specific strain being examined (WT Ampicillin: 8 μg/ml; WT Oxydifficidin: 2 μg/ml; ΔdedA Oxydifficidin: 16 μg/ml). ΔdedA indicates N. gonorrhoeae dedA deletion mutant. (n = 3)
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_fig3.tif/full/max/0/default.jpg)
Oxydifficidin’s anti-N. gonorrhoeae activity arises from a combination of DedA flippase assisted uptake and ribosomal protein L7/L12 (RplL) sensitivity.
a. Structure of oxydifficidin compared to that of the known substrates for DedA homologs. b. Comparison of antibiotic accumulation in WT and dedA knockout cells. Blue and yellow highlighted sections represent independent experiments. (Oxydifficidin and Tetracycline: n = 2; Oxydifficidin and chloramphenicol: n = 3) c. In vitro coupled transcription/translation assay. The effect of oxydifficidin and other antibiotics on in vitro protein production using a coupled transcription/translation system was monitored by SDS-PAGE. Red dots indicate in vitro production of dihydrofolate reductase (18 kDa) from the DHFR gene. MW std: kDa molecular weight standard. d. In vitro transcription assay. Red dots indicate in vitro production of a 1704 bp RNA from the FLuc gene. A reaction containing 20 mM of EDTA was used as an inhibition control. MW std: bp molecular weight standard. e. Model explaining oxydifficidin’s potent activity in N. gonorrhoeae. In this model DedA flips oxydifficidin across the inner membrane to assist its uptake and oxydifficidin then inhibits protein synthesis through either a direct or indirect interaction with L7/L12 (RplL). Two spontaneous mutations (K84E and R76C) in the RplL (L7/L12) protein were found to confer resistance to oxydifficidin. Image was generated by BioRender.
© 2024, BioRender Inc. Any parts of this image created with BioRender are not made available under the same license as the Reviewed Preprint, and are © 2024, BioRender Inc.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_tbl2.tif/full/max/0/default.jpg)
Activity of antibiotics against N. gonorrhoeae rplL mutant.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_figs1.tif/full/max/0/default.jpg)
Mutagenesis results of oxydifficidin-producing Bacillus spp.
a. Genome-based phylogenetic tree containing Bacillus amyloliquefaciens BK and closely related Bacillus spp.. The tree was built using Genome Clustering of MicroScope. b. Disc diffusion assay of a methanol extract from cultures of WT Bacillus amyloliquefaciens BK (WT) and a Tn5 mutant. The test lawn was N. gonorrhoeae. The table shows all transposon insertion sites in the Tn5 mutant strain. The Tn5 also contains a frame-shift mutation in the difF gene. The red box highlights the location of frame-shift mutation in the oxydifficidin BGC. c. Disc diffusion assay of a methanol extract from cultures of WT and BGC knockout strains of Bacillus amyloliquefaciens FZB42. The test lawn was N. gonorrhoeae. Strain genotypes are shown in the table. Red arrow indicates that only strain 10A15 no longer produce the anti-N. gonorrhoeae compound.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_figs2.tif/full/max/0/default.jpg)
Phylogenetic tree of 15,825 bacterial DedA family proteins.
The tree was built by MUSCLE v5 and FastTree and visualized using iTOL. N. gonorrhoeae NGFG_RS04905 highlighted in red represents the DedA gene associated with the activity of oxydifficidin. N. gonorrhoeae NGFG_RS07420 and N. gonorrhoeae NGFG_RS00755 represents 2 other DedA family proteins in N. gonorrhoeae.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_figs3.tif/full/max/0/default.jpg)
Oxydifficidin does not lyse or depolarize the membrane of N. gonorrhoeae.
a. Lysis assay using SYTOX green dye and 8x the MIC of each antibiotic. b. Depolarization assay using DiSC3(5) dye and 8x the MIC of each antibiotic. c. Lysis assay using SYTOX green dye with 100x the MIC of oxydifficidin and 32x the MIC of nisin. d. Depolarization assay using DiSC3(5) dye with 100x the MIC of oxydifficidin and the 32x the MIC of melittin. (n = 3 for all assays)
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_figs4.tif/full/max/0/default.jpg)
Mutations in dedA affect cell morphology and pili functionality of N. gonorrhoeae.
a. Membrane integrity assay of N. gonorrhoeae WT and dedA deletion mutant (ΔdedA) cells using SYTO 9 and propidium iodide. Cell integrity was assessed using the ratio of green-stained cell count to red-stained cell count. *: p < 0.05 b. Scanning electron microscope pictures of N. gonorrhoeae WT and ΔdedA cells. c. Micro-colony formation assay of N. gonorrhoeae WT and ΔdedA cells.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_figs5.tif/full/max/0/default.jpg)
1H-NMR spectrum of oxydifficidin (800 MHz, 298 K, CD3OD - D2O (1:1)).
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_figs6.tif/full/max/0/default.jpg)
13C-NMR spectrum of oxydifficidin (800 MHz, 298 K, CD3OD - D2O (1:1)).
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_figs7.tif/full/max/0/default.jpg)
edHSQC spectrum (800 MHz, 298 K, CD3OD - D2O (1:1)) of oxydifficidin.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_figs8.tif/full/max/0/default.jpg)
COSY spectrum (800 MHz, 298 K, CD3OD - D2O (1:1)) of oxydifficidin.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_figs9.tif/full/max/0/default.jpg)
1H-13C HMBC spectrum (800 MHz, 298 K, CD3OD - D2O (1:1)) of oxydifficidin.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_figs10.tif/full/max/0/default.jpg)
Partial COSY (left) and ROESY (right) comparison and key ROESY correlations of oxydifficidin (800 MHz, 298 K, CD3OD - D2O (1:1)).
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_figs11a.tif/full/max/0/default.jpg)
Full HRMS and annotation of oxydifficidin [M–H]− parental ion.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_figs11b.tif/full/max/0/default.jpg)
-ESI MS/MS spectrum and fragment annotation of oxydifficidin [M–H]− ion.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_tbls1.tif/full/max/0/default.jpg)
Activity of oxydifficidin against of Neisseria mutants.
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_tbls2.tif/full/max/0/default.jpg)
1H and 13C NMR data of oxydifficidin (800 MHz, 298 K, CD3OD - D2O (1:1))
![](https://prod--epp.elifesciences.org/iiif/2/99281%2Fv1%2Fcontent%2F596031v1_tbls3.tif/full/max/0/default.jpg)